Back to Results
First PageMeta Content
Medicine / Coagulation / Health / Von Willebrand disease / Haemophilia / Bioavailability


CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research STN[removed]Sponsor: Novo Nordisk Product: Antihemophilic Factor (recombinant), plasma/albumin free (NovoEight) Turoctocog alfa
Add to Reading List

Open Document

File Size: 957,22 KB

Share Result on Facebook

Company

Novo Nordisk / /

Event

FDA Phase / /

MedicalCondition

hemophilia A. Treatment / sex-linked hereditary disorder / hemophilia A / hemophilia / Factor deficiency / severe hemophilia A / Action Hemophilia / /

Organization

FDA / Hematology Office / CLINICAL PHARMACOLOGY BLA REVIEW Division / /

Person

Basil Golding / Leigh Pracht / /

Position

Director / Division / /

Product

VIII / Novoeight / /

Technology

pharmacokinetics / Pharmacodynamics / /

SocialTag